Mark Lackner

Mark Lackner serves as the Chief Scientific Officer at Zentalis Pharmaceuticals, where responsibilities encompass overseeing scientific activities from drug discovery to clinical development. Concurrently, Mark holds the position of Chief Translational Officer and Head of Biomarker Strategy at Onc.AI. Previously, Mark was the Senior Vice President at IDEAYA Biosciences, leading Biology and Translational Sciences. Mark's experience includes a significant tenure at Genentech, where roles ranged from Director & Principal Scientist for Oncology Biomarker Development to Senior Scientist. Mark's early career includes positions at Exelixis and postdoctoral research at UC Berkeley. Academic credentials include a PhD in Developmental Biology from Stanford University and a Postdoctoral fellowship in Molecular Genetics from UC Berkeley.